Charles Schwab’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$316M Buy
4,036,837
+75,194
+2% +$5.88M 0.05% 283
2025
Q1
$287M Buy
3,961,643
+198,882
+5% +$14.4M 0.05% 287
2024
Q4
$279M Buy
3,762,761
+103,659
+3% +$7.67M 0.05% 291
2024
Q3
$241M Buy
3,659,102
+53,181
+1% +$3.51M 0.05% 323
2024
Q2
$333M Buy
3,605,921
+31,349
+0.9% +$2.9M 0.06% 258
2024
Q1
$342M Buy
3,574,572
+125,718
+4% +$12M 0.08% 225
2023
Q4
$263M Buy
3,448,854
+5,669
+0.2% +$432K 0.07% 261
2023
Q3
$239M Buy
3,443,185
+104,382
+3% +$7.23M 0.07% 252
2023
Q2
$315M Buy
3,338,803
+6,467
+0.2% +$610K 0.09% 197
2023
Q1
$276M Buy
3,332,336
+62,350
+2% +$5.16M 0.08% 208
2022
Q4
$244M Buy
3,269,986
+122,607
+4% +$9.15M 0.08% 230
2022
Q3
$260M Sell
3,147,379
-9,269
-0.3% -$766K 0.09% 195
2022
Q2
$300M Buy
3,156,648
+51,520
+2% +$4.9M 0.1% 181
2022
Q1
$366M Buy
3,105,128
+80,881
+3% +$9.52M 0.11% 166
2021
Q4
$392M Buy
3,024,247
+85,550
+3% +$11.1M 0.12% 159
2021
Q3
$333M Buy
2,938,697
+59,772
+2% +$6.77M 0.11% 164
2021
Q2
$298M Buy
2,878,925
+18,383
+0.6% +$1.9M 0.1% 181
2021
Q1
$239M Sell
2,860,542
-259,457
-8% -$21.7M 0.09% 199
2020
Q4
$285M Sell
3,119,999
-239,279
-7% -$21.8M 0.11% 167
2020
Q3
$268M Sell
3,359,278
-64,985
-2% -$5.19M 0.12% 150
2020
Q2
$237M Buy
3,424,263
+170,523
+5% +$11.8M 0.12% 167
2020
Q1
$205M Buy
3,253,740
+64,089
+2% +$4.03M 0.12% 159
2019
Q4
$248M Buy
3,189,651
+239,235
+8% +$18.6M 0.13% 142
2019
Q3
$216M Buy
2,950,416
+64,569
+2% +$4.73M 0.13% 151
2019
Q2
$178M Sell
2,885,847
-67,410
-2% -$4.15M 0.11% 178
2019
Q1
$188M Buy
2,953,257
+452,181
+18% +$28.8M 0.12% 154
2018
Q4
$128M Buy
2,501,076
+62,175
+3% +$3.17M 0.1% 186
2018
Q3
$142M Buy
2,438,901
+54,900
+2% +$3.19M 0.09% 189
2018
Q2
$116M Buy
2,384,001
+79,038
+3% +$3.84M 0.08% 219
2018
Q1
$107M Buy
2,304,963
+133,467
+6% +$6.21M 0.08% 230
2017
Q4
$81.6M Buy
2,171,496
+86,463
+4% +$3.25M 0.06% 285
2017
Q3
$76M Buy
2,085,033
+109,269
+6% +$3.98M 0.07% 285
2017
Q2
$77.9M Buy
1,975,764
+58,470
+3% +$2.3M 0.07% 269
2017
Q1
$60.1M Buy
1,917,294
+102,276
+6% +$3.21M 0.06% 310
2016
Q4
$56.7M Sell
1,815,018
-108,924
-6% -$3.4M 0.06% 304
2016
Q3
$77.3M Buy
1,923,942
+132,012
+7% +$5.31M 0.09% 223
2016
Q2
$59.6M Sell
1,791,930
-35,055
-2% -$1.17M 0.07% 270
2016
Q1
$53.7M Buy
1,826,985
+24,597
+1% +$723K 0.07% 285
2015
Q4
$47.5M Buy
1,802,388
+85,176
+5% +$2.24M 0.06% 295
2015
Q3
$40.7M Sell
1,717,212
-275,658
-14% -$6.53M 0.06% 306
2015
Q2
$47.3M Sell
1,992,870
-375,564
-16% -$8.92M 0.07% 288
2015
Q1
$56.2M Sell
2,368,434
-99,048
-4% -$2.35M 0.08% 251
2014
Q4
$52.4M Buy
2,467,482
+150,384
+6% +$3.19M 0.08% 248
2014
Q3
$39.4M Buy
2,317,098
+841,416
+57% +$14.3M 0.06% 283
2014
Q2
$21.1M Buy
1,475,682
+32,874
+2% +$470K 0.04% 471
2014
Q1
$17.8M Buy
1,442,808
+20,334
+1% +$251K 0.03% 505
2013
Q4
$15.6M Buy
1,422,474
+55,434
+4% +$608K 0.03% 513
2013
Q3
$16.2M Buy
1,367,040
+38,610
+3% +$459K 0.03% 462
2013
Q2
$14.8M Buy
+1,328,430
New +$14.8M 0.03% 459